PATENT CLAIM ANALYSIS

Application Number: 15986470
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "014900"]

Abstract:
Provided herein are compounds that inhibit a binding interaction between a β integrin and a G protein subunit, as well as compositions, e.g., pharmaceutical compositions, comprising the same, and related kits. In some embodiments, the compound is an antibody or antibody analog, and, in other embodiments, the compound is a peptide or peptide analog. Also provided are methods of using the compounds, including methods of treating or preventing a medical condition, such as stroke, heart attack, cancer, or inflammation.

Claim (Index 25):
The peptide or peptide analog of  claim 23 , wherein Xaa 4  is Leu.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 93.0
- Lexical Diversity: 1.71429
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14176930', '14843152', '13621064', '12611446', '11579291']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8025267274186153
- 35 USC 102 Novelty (BERT): 0.6078825695235218
- Combined Prediction Score: 0.783062311629106
- Mean Citation Score: 484.241366
- Max Citation Score: 617.70734
- Similarity Product: 437.0540722090364

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test